Evidence map›Paper›PMID 31512001›Full record

ArticlePharmaceutical research2019

Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein.

Naoto Hashimoto, Noritaka Nakamichi, Hikari Nanmo, Kei-Ichi Kimura, Yusuke Masuo, Yasuyuki Sakai, Alfred H Schinkel, Shinichi Sato, Tomoyoshi Soga, Yukio Kato

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring the Metabolic Effects of a Herbal Remedy ofAntioxidants (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Current Knowledge in Skin Metabolomics: Updates from Literature Review.International journal of molecular sciences · 2022
    Review
  7. Article
  8. ABCB1 in dermatology: roles in skin diseases and their treatment.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Naoto HashimotoFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan.
Noritaka NakamichiFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan.
Hikari NanmoFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan.
Kei-Ichi KimuraDepartment of Bioengineering, Graduate School of Engineering, University of Tokyo, Tokyo, Japan.
Yusuke MasuoFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan.
Yasuyuki SakaiDepartment of Chemical System Engineering, Graduate School of Engineering, University of Tokyo, Tokyo, Japan.
Alfred H SchinkelThe Netherlands Cancer Institute, Amsterdam, The Netherlands.
Shinichi SatoDepartment of Dermatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Tomoyoshi SogaInstitute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
Yukio KatoFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan. ykato@p.kanazawa-u.ac.jp.
Kanazawa University · JPThe University of Tokyo · JPKeio University · JPThe Netherlands Cancer Institute · NL

Funding

Japan Society for the Promotion of Science S2601Ministry of Education, Culture, Sports, Science and Technology 16K08266Ministry of Education, Culture, Sports, Science and Technology 25670011
6 · The paper itself

Abstract

purposeP-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) are xenobiotic transporters which pump out variety types of compounds, but information on their interaction with endogenous substrates in the skin is limited. The purpose of the present study was to clarify possible association of these transporters in dermal accumulation of inflammatory mediators.

methodsDermatitis model was constructed by repeated topical application of oxazolone in wild-type, and P-gp and BCRP gene triple knockout (Mdr1a/1b/Bcrp

resultsDermatitis and scratching behavior in dermatitis model of Mdr1a/1b/Bcrp

conclusionsThese results suggest possible association of these efflux transporters with dermal inflammatory mediators, and such association could be observed in the dermatitis skin.

Indexed as

AnimalsATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily G, Member 2DermatitisGene DeletionHistamineHumansMaleMetabolomeMiceMice, KnockoutNeoplasm ProteinsSkinABCG2 protein, humanATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily G, Member 2HistamineNeoplasm Proteinsbreast cancer resistance proteindermatitishistaminemetabolomicsP-glycoprotein

Identifiers

PMID31512001
OpenAlexW2973199885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.